BW
GILD icon

Blalock Williams’s Gilead Sciences GILD Stock Holding History

Blalock Williams’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Sell
4,661
-17
-0.4% -$2.24K 0.38% 67
2026
Q1 		$652K Sell
4,678
-7
-0.1% -$980 0.5% 54
2025
Q4 		$575K Sell
4,685
-133
-3% -$16.2K 0.46% 54
2025
Q3 		$535K Buy
4,818
+268
+6% +$30.5K 0.47% 56
2025
Q2 		$504K Buy
4,550
+1,081
+31% +$115K 0.5% 55
2025
Q1 		$389K Buy
3,469
+299
+9% +$30.9K 0.44% 67
2024
Q4 		$293K Buy
+3,170
New +$285K 0.34% 76

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Blalock Williams's GILD Position: Q2 2026 in Review

Blalock Williams reduced its Gilead Sciences (GILD) stake by 0.36% in Q2 2026, selling an estimated $2.24K and leaving 4,661 shares worth $589K. The position accounts for 0.38% of the portfolio, ranked #67.

Blalock Williams first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $652K in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Blalock Williams held 4,661 shares of Gilead Sciences worth $589K as of Q2 2026.
  • Blalock Williams sold 17 Gilead Sciences shares in Q2 2026, an estimated $2.24K.
  • Gilead Sciences made up 0.38% of Blalock Williams's portfolio in Q2 2026, its #67 holding.
  • Blalock Williams first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Blalock Williams's Gilead Sciences position peaked at $652K in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Blalock Williams's 13F filing for Q2 2026, filed 7 Aug 2026.